PolyMedica shares soar as SEC (US Securities and Exchange Committee) ends inquiry
This article was originally published in Clinica
Shares in PolyMedica leapt by over 50% to around $39 after the US Securities and Exchange Committee (SEC) ended an inquiry into the company. However, the company is still the subject of an investigation by the Department of Justice.
You may also be interested in...
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.
Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.